• 1
    Bartter FC. The syndrome of inappropriate secretion of antidiuretic hormone. Endocrine and Neuroendocrine Hormone Producing Tumors Year Book Medical Publishers, Chicago, 1973; 1159.
  • 2
    Vorherr H, Massry SG, Utiger RD, Kleeman CR. Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J. Clin. Endocrinol. 1968; 29: 1624.
  • 3
    Sellwood RA, Spencer J, Azzopardi JG, Wapnik S, Welbourn RB, Kulatilake AE. Inappropriate secretion of antidiuretic hormone by carcinoma of the prostate. Br. J. Surg. 1969; 56: 9336.
  • 4
    Sacks SA, Rhodes DB, Malkasian DR, Robenbloom AA. Prostatic carcinoma producing syndrome of inappropriate secretion of antidiuretic hormone. Urology 1975; 6: 48992.
  • 5
    Tisher CC. Correction of an inappropriate ADH synthesis by tumor resection. Arch. Intern. Med. 1968; 121: 1637.
  • 6
    North WG. Human neurophysin as potential tumor markers for small cell carcinoma of the lung: Application of specific radioimmunoassays. J. Clin. Endocrinol. Metab. 1980; 51: 8927.
  • 7
    Saito T, Ishikawa S, Abe K et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (ADH). J. Clin. Endocrinol. Metab. 1997; 82: 1054.
  • 8
    Ichikawa T, Suzuki H, Ito H. Role of chromosomal loss in the progression of prostate cancers. Int. J. Clin. Oncol. 2000; 5: 34554.